Last reviewed · How we verify

NCT04947215

The Association Between LPCAT1 Genetic Polymorphism and Stress Biomarkers in Neonatal Respiratory Distress Syndrome

Status unknown Last updated 1 July 2021
What this trial tests

trial testing stress biomarkers in Neonatal Respiratory Distress in 160 participants. Status unknown.

Timeline
1 August 2021
Primary endpoint
30 June 2022
31 July 2022

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment160
Start date1 August 2021
Primary completion30 June 2022
Estimated completion31 July 2022
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 1 Hour to 1 Month, any sex, with Neonatal Respiratory Distress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aims of the Research Primary: 1. Measure the levels of stress biomarkers in full and preterm neonates with normal and complicated pregnancies and to study the influence of delivery mode on their cord blood concentrations. 2. Test the association between LPCAT1 genetic polymorphism and the levels of these biomarkers in neonates suffering from RDS. 3. Study the relation between LPCAT1 genetic polymorphism and the risk/severity of neonatal respiratory distress syndrome. Secondary: 1\) Help understanding the possible etiology and pathogenesis of neonatal RDS. 2) Help the possibility of early detection, diagnosis and management. 3\) Help to decrease mortality and morbidity in selective cases. 4) Understand the individual variability in the susceptibility to development of pulmonary pathologies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of stress biomarkers

Trials testing the same drug.

Other recruiting trials for Neonatal Respiratory Distress

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04947215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing